Skip to main content

AstraZeneca COVID vaccine pause seen as 'Mixed blessing' for competitors

SVB Leerink analyst Andrew Berens believes the overall pace of many other COVID programs could also be impacted.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.